Evidence map›Paper›PMID 29666903›Full record

ArticleEuropean journal of clinical pharmacology2018

High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis.

Elena Arsiè, Stefania Piconi, Massimo Iavarone, Valeria Cozzi, Pietro Lampertico, Dario Cattaneo

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Isavuconazole-Animal Data and Clinical Data.Journal of fungi (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elena Arsiè"A.M. e A. Migliavacca" Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Via Francesco Sforza 35, 20122, Milan, Italy. elena.arsie@unimi.it.ORCID http://orcid.org/0000-0002-2492-0798
Stefania PiconiDepartment of Infectious Diseases, ASST Fatebenefratelli Sacco, University Hospital, Milan, Italy.
Massimo Iavarone"A.M. e A. Migliavacca" Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Via Francesco Sforza 35, 20122, Milan, Italy.
Valeria CozziUnit of Clinical Pharmacology, ASST Fatebenefratelli Sacco, University Hospital, Milan, Italy.
Pietro Lampertico"A.M. e A. Migliavacca" Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Via Francesco Sforza 35, 20122, Milan, Italy.
Dario CattaneoUnit of Clinical Pharmacology, ASST Fatebenefratelli Sacco, University Hospital, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsHumansInvasive Pulmonary AspergillosisLiver CirrhosisMaleMiddle AgedNitrilesPyridinesTriazolesAntifungal AgentsisavuconazoleNitrilesPyridinesTriazoles

Identifiers

PMID29666903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.